We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Settles with Roche, Genentech; Clearing Path for Herceptin Biosimilar
Mylan Settles with Roche, Genentech; Clearing Path for Herceptin Biosimilar
Mylan reached a settlement with Roche and Genentech that paves the way for the generic drugmaker to market a biosimilar version of the blockbuster drug Herceptin.